[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336415-105":59,"doc-detail-336415-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","accurate-early-detection-and-egfr-mutation-status-prediction-of-lung-cancer-using-plasma-cfdna-coverage-patterns-a-proof-of-concept-study","Accurate Early Detection and EGFR Mutation Status Prediction of Lung Cancer Using Plasma cfDNA Coverage Patterns - A Proof-of-Concept Study","","Lung cancer is a major global health concern with low survival, largely driven by late-stage diagnosis. Liquid biopsy provides a non-invasive option using circulating cell-free DNA (cfDNA). This study builds two machine learning models from cfDNA coverage patterns at transcription start sites (TSSs) using 6X whole-genome sequencing: an Early Cancer Screening Model and an EGFR mutation status prediction model. The screening model showed strong performance for early-stage lung cancer, while the EGFR model accurately distinguished EGFR-positive from wild-type cases. The work also links TSS coverage patterns to pathway-level gene expression, supporting cfDNA-based screening and cancer subtyping applications.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/accurate-early-detection-and-egfr-mutation-status-prediction-of-lung-cancer-using-plasma-cfdna-coverage-patterns-a-proof-of-concept-study/336415/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/accurate-early-detection-and-egfr-mutation-status-prediction-of-lung-cancer-using-plasma-cfdna-coverage-patterns-a-proof-of-concept-study/336415.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data and genomic coverage information does the study use?","Question",{"text":112,"@type":113},"The study uses cfDNA coverage patterns at transcription start sites (TSSs) derived from 6X whole-genome sequencing.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What models are developed in the paper?",{"text":117,"@type":113},"Two models are developed: an Early Cancer Screening Model and an EGFR mutation status prediction model.",{"name":119,"@type":110,"acceptedAnswer":120},"How do the models perform for early-stage detection and EGFR status?",{"text":121,"@type":113},"The Early Cancer Screening Model shows encouraging prediction ability, especially for early-stage lung cancer. The EGFR model demonstrates high accuracy in distinguishing EGFR-positive from wild-type cases.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336415,1790120215,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","biomolecules  \nArticle  \nAccurate Early Detection and EGFR Mutation Status Prediction of Lung Cancer Using Plasma cfDNA Coverage Patterns: A Proof-of-Concept Study  \nZhixin Bie 1,†, Yi Ping 2,†, Xiaoguang Li 1, Xun Lan 2,3,4,5,* and Lihui Wang 2, *  \nCitation: Bie, Z.; Ping, Y.; Li, X.; Lan, X.; Wang, L. Accurate Early Detection and EGFR Mutation Status Prediction of Lung Cancer Using Plasma cfDNA Coverage Patterns: A Proof-ofConcept Study. Biomolecules 2024, 14, 716. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biom14060716  \nAcademic Editors: Anthony J. Berdisand Peter Celec  \nReceived: 3 April 2024  \nRevised: 2 June 2024  \nAccepted: 10 June 2024  \nPublished: 17 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Minimally Invasive Tumor Therapies Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 Dongdan Dahua Street, Beijing 100730, China; [biezhixin3910@bjhmoh.cn](biezhixin3910@bjhmoh.cn) (Z.B.); [lixiaoguang4678@bjhmoh.cn](lixiaoguang4678@bjhmoh.cn) (X.L.)  \n2 Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China; [pingyi900@gmail.com](pingyi900@gmail.com)  \n3 Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China  \n4 Centre for Life Sciences, Tsinghua University, Beijing 100084, China  \n5 MOE Key Laboratory of Bioinformatics, Tsinghua University, Beijing 100084, China  \n* [Correspondence: xlan@mail.tsinghua.edu.cn](Correspondence: xlan@mail.tsinghua.edu.cn) (X.L.); [wanglh2018@mail.tsinghua.edu.cn or wlhlucky@163.com](wanglh2018@mail.tsinghua.edu.cn or wlhlucky@163.com) (L.W.)† These authors contributed equally to this work.  \nAbstract: Lung cancer is a major global health concern with a low survival rate, often due to latestage diagnosis. Liquid biopsy offers a non-invasive approach to cancer detection and monitoring, utilizing various features of circulating cell-free DNA (cfDNA) . In this study, we established two models based on cfDNA coverage patterns at the transcription start sites (TSSs) from 6X wholegenome sequencing: an Early Cancer Screening Model and an EGFR mutation status prediction model. The Early Cancer Screening Model showed encouraging prediction ability, especially for early-stage lung cancer. The EGFR mutation status prediction model exhibited high accuracy in distinguishing between EGFR-positive and wild-type cases. Additionally, cfDNA coverage patterns at TSSs also reflect gene expression patterns at the pathway level in lung cancer patients. These findings demonstrate the potential applications of cfDNA coverage patterns at TSSs in early cancer screening and in cancer subtyping.  \nKeywords: cfDNA; coverage patterns at the transcription start sites; early cancer screening; EGFR mutation status prediction; machine learning  \n1. Introduction  \nLung cancer remains the leading cause of cancer-related deaths worldwide, significantly impacting global public health. The 5-year survival rate for lung cancer is only 10% to 20%, mainly due to its rapid progression and often late-stage diagnosis, leading to treatment complexity and decreased survival rates [1] . Most patients are diagnosed with advanced-stage disease (stage III or IV), with a less than 5% 5-year survival rate. More than half of lung cancer patients die within one year of diagnosis [2] . Patients diagnosed in early or mid stages have a better prognosis than those in later stages, with higher chances of successful treatment, highlighting the importance of screening for early cancer detection and improved prognosis. ","cbCaisSqFeYOx5xe","https://ap.wps.com/l/cbCaisSqFeYOx5xe","pdf",17050248,14,"English","# Introduction\n## Liquid biopsy and cfDNA features\n## Rationale for using TSS coverage patterns\n## Study contribution and models","[{\"question\":\"What data and genomic coverage information does the study use?\",\"answer\":\"The study uses cfDNA coverage patterns at transcription start sites (TSSs) derived from 6X whole-genome sequencing.\"},{\"question\":\"What models are developed in the paper?\",\"answer\":\"Two models are developed: an Early Cancer Screening Model and an EGFR mutation status prediction model.\"},{\"question\":\"How do the models perform for early-stage detection and EGFR status?\",\"answer\":\"The Early Cancer Screening Model shows encouraging prediction ability, especially for early-stage lung cancer. The EGFR model demonstrates high accuracy in distinguishing EGFR-positive from wild-type cases.\"}]","Accurate Early Detection and EGFR Mutation Status Prediction of Lung Cancer Using Plasma cfDNA Coverage Patterns - A Proof-of-Concept Study | PDF",1790014947,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f279f39c59e37a737914ca900c2c2cf5.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11d4c6ffc8b1c27724d1528f30f9151b.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f545615e17644093cf634dda5be64737.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/acd1a4d9e563f2249bb7898a56ca9484.webp",980,1385]